detalle del documento
IDENTIFICACIÓN

oai:www.zora.uzh.ch:229009

Tema
Clinic for Psychiatry, Psychothera... 610 Medicine & health
Autor
Küçükali, Fahri Neumann, Alexander Van Dongen, Jasper et al Popp, Julius https://orcid.org/0000-0002-0068-0312
Langue
eng
Editor

Wiley-Blackwell Publishing, Inc.

Categoría

Subjects = 04 Faculty of Medicine

Año

2023

fecha de cotización

12/10/2023

Palabras clave
traits biomarker novel variation rare whole-exome disease alzheimer
Métrico

Resumen

INTRODUCTION Despite increasing evidence of a role of rare genetic variation in the risk of Alzheimer's disease (AD), limited attention has been paid to its contribution to AD-related biomarker traits indicative of AD-relevant pathophysiological processes.

METHODS We performed whole-exome gene-based rare-variant association studies (RVASs) of 17 AD-related traits on whole-exome sequencing (WES) data generated in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study (n = 450) and whole-genome sequencing (WGS) data from ADNI (n = 808).

RESULTS Mutation screening revealed a novel probably pathogenic mutation (PSEN1 p.Leu232Phe).

Gene-based RVAS revealed the exome-wide significant contribution of rare coding variation in RBKS and OR7A10 to cognitive performance and protection against left hippocampal atrophy, respectively.

DISCUSSION The identification of these novel gene-trait associations offers new perspectives into the role of rare coding variation in the distinct pathophysiological processes culminating in AD, which may lead to identification of novel therapeutic and diagnostic targets.

Küçükali, Fahri,Neumann, Alexander,Van Dongen, Jasper,et al,Popp, Julius, https://orcid.org/0000-0002-0068-0312, 2023, Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits, Wiley-Blackwell Publishing, Inc.

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA